UnitedHealth Group Inc (UNH) Holdings Reduced by Trust Investment Advisors

Trust Investment Advisors reduced its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 5.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 10,135 shares of the healthcare conglomerate’s stock after selling 600 shares during the period. UnitedHealth Group makes up approximately 2.2% of Trust Investment Advisors’ holdings, making the stock its 5th biggest holding. Trust Investment Advisors’ holdings in UnitedHealth Group were worth $1,985,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Marshall Wace LLP raised its holdings in UnitedHealth Group by 441.4% during the 2nd quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after buying an additional 11,361 shares during the period. American Century Companies Inc. raised its holdings in UnitedHealth Group by 16.9% during the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after buying an additional 681,111 shares during the period. Schwab Charles Investment Management Inc. raised its holdings in UnitedHealth Group by 5.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after buying an additional 183,401 shares during the period. Essex Financial Services Inc. raised its holdings in UnitedHealth Group by 12.3% during the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after buying an additional 967 shares during the period. Finally, Factory Mutual Insurance Co. raised its holdings in UnitedHealth Group by 20.9% during the 2nd quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock worth $77,245,000 after buying an additional 72,000 shares during the period. Hedge funds and other institutional investors own 86.01% of the company’s stock.

Several brokerages have commented on UNH. Evercore ISI restated an “outperform” rating and set a $255.00 target price (up from $235.00) on shares of UnitedHealth Group in a report on Friday. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a report on Wednesday, October 18th. Cantor Fitzgerald reiterated a “buy” rating and issued a $208.00 price objective on shares of UnitedHealth Group in a report on Tuesday, October 17th. Finally, Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a report on Wednesday, October 18th. Three analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $229.54.

In related news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares in the company, valued at $13,652,503.47. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 34,630 shares of company stock worth $7,669,416. 0.89% of the stock is owned by corporate insiders.

UnitedHealth Group Inc (NYSE:UNH) opened at $228.64 on Friday. The firm has a market cap of $221,060.00, a price-to-earnings ratio of 25.98, a P/E/G ratio of 1.53 and a beta of 0.66. UnitedHealth Group Inc has a fifty-two week low of $156.09 and a fifty-two week high of $231.77. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the previous year, the company earned $2.17 earnings per share. analysts anticipate that UnitedHealth Group Inc will post 9.99 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Week Herald and is owned by of Week Herald. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://weekherald.com/2018/01/14/unitedhealth-group-inc-unh-holdings-reduced-by-trust-investment-advisors.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply